K+S AG Overview
K+S is Europe's leading — and one of the world's six or seven largest — producers of potash and magnesium fertilizers, combined with one of Europe's largest salt businesses. After divesting its North and South American salt operations (Morton Salt, Windsor Salt, K+S Chile) to Stone Canyon in 2021, the group has become a focused minerals company with two customer segments: Agriculture (~70% of revenue: potassium chloride and high-margin specialty fertilizers such as Korn-Kali, Patentkali, KALISOP and EPSO products) and Industry+ (~30%: industrial and pharmaceutical potash and magnesium compounds, de-icing, food, water-softening and chemical salts, plus waste-management services). Its production base comprises six German underground potash/magnesium operations centered on the Werra complex and Zielitz, the greenfield Bethune solution mine in Saskatchewan, Canada, and European salt plants. Its competitive identity rests on a unique specialties portfolio and proximity to European customers; its structural challenge is a high-cost, environmentally constrained German asset base whose transformation ("Werra 2060") and the Bethune ramp-up absorb most cash flow through 2028.
What K+S does. K+S mines potash- and magnesium-bearing crude salts and rock salt, and processes them into fertilizers, industrial chemicals, and salt products. The company's own boilerplate (FY2025 press materials) describes its mission as enabling farmers to secure the world's food supply, keeping industries running, enriching consumers' daily lives and ensuring winter road safety, with production on two continents and a global distribution network. Management explicitly frames the group as "realigning" toward fertilizers and specialties, becoming leaner, more cost-efficient, more digital and more performance-oriented.
Business model. K+S is a vertically integrated, asset-heavy commodity-plus-specialty producer. Value is created at the mine and processing plant; it owns (or holds long-dated concessions over) its deposits and controls logistics assets (port terminals, rail/barge contracts). Revenue is almost entirely product sales (>95%); services (REKS waste management/underground reuse, logistics) are a small, non-separately-disclosed share. There is no subscription or licensing revenue of significance.
Revenue model mix (FY2025, company data):
Source: K+S Q4/2025 Facts & Figures. Note: KCl + specialties sum (2,547.7) equals the Agriculture segment total including trade goods.
Value-chain position. Upstream (mining, beneficiation, granulation) through to distribution: K+S sells to fertilizer distributors, cooperatives, blenders and importers (overseas: Brazil, Southeast Asia, North America), to chemical/pharma/food industries, to municipalities/road authorities (de-icing tenders) and, via retailers, to consumers (water softening, table salt in some markets). It does not produce nitrogen or phosphate.
Customer types and end-markets: (i) Agriculture — row crops (Brazil soy/corn/sugarcane), specialty and chloride-sensitive crops in Europe (potatoes, fruit, vegetables, vines), oil palm and rice in Asia; (ii) Industry — chemicals (KOH production, PVC/chlor-alkali salt), oil & gas drilling brines, food processing, pharmaceuticals and dialysis (high-purity salts), animal feed, water treatment; (iii) Communities — municipal and highway de-icing; (iv) Consumers — water-softener salt, table salt.
Independent characterization. K+S is best understood as a high-cost, specialty-tilted potash producer with a counter-cyclical (weather-driven) salt hedge. Unlike Nutrien or Mosaic, its legacy German operations are conventional underground mines with comparatively deep, low-grade, mixed deposits (kieserite-, carnallite- and sylvinite-bearing) that require energy-intensive hot-leach or flotation processing and generate large volumes of saline residues — the root of its water-disposal and tailings-pile constraints. That geology, however, is also its moat: the magnesium and sulfate content enables a specialties portfolio (sulfate of potash, kieserite, Epsom salt, K-Mg compound fertilizers) that commands a premium (FY2025 specialties average €374.6/t vs. KCl €309.6/t). Bethune in Canada provides a lower-cost, USD-denominated, solution-mined KCl platform but has struggled to reach nameplate capacity. Earnings are levered to the Brazilian KCl price, the USD/EUR rate, European natural gas, and winter severity.
Strategy
10.1 Stated strategy themes. K+S's current positioning (FY2025 Annual Report boilerplate and CEO statements) emphasises: (1) a sharper focus on fertilizers and specialties; (2) becoming leaner, more cost-efficient, more digital and more performance-oriented; (3) tapping new markets and business models on a solid financial basis; (4) responsibility toward society and environment. On taking office, CEO Meyer identified the successful transformation of the company as the greatest challenge, with digitalisation, the energy transition and strategic use of artificial intelligence as priorities. In March 2026 management added a commitment to optimise resource allocation, structures and processes (including costs) so that K+S can continue to fund both major projects internally. The predecessor strategy "Shaping 2030" (launched under Lohr) remains the conceptual frame (portfolio focus, specialties, waste-management business, balance-sheet strength).
10.2 Major strategic initiatives (last 24 months)
10.3 Guidance and medium-term targets
Medium-term financial policy: maintain investment-grade-consistent capital structure; distribute 30–50% of adjusted FCF. No formal medium-term (e.g., 2030) revenue/EBITDA targets were identified in the sources reviewed.
Products & Services
K+S does not disclose product-level revenue or list prices; pricing is negotiated (spot/contract, regional price references such as Brazil CFR granular MOP). Brand names below are K+S fertilizer and salt brands as marketed on its product websites; launch years are generally decades old and not disclosed unless stated.
5.1 Agriculture — Potassium chloride (MOP)
FY2025: KCl revenue €1,371.3M, 4.43 Mt, average €309.6/t (Q4/2025 Facts & Figures).
5.2 Agriculture — Fertilizer specialties
FY2025: specialties revenue €1,176.4M, 3.14 Mt, average €374.6/t (Q4/2025 Facts & Figures).
5.3 Industry+ — Potash and magnesium for industry
5.4 Industry+ — Salt
Qemetica's salt sites (Janikowo, Stassfurt; pending acquisition) add evaporated specialty salts for water softening and food (company press release 12 Aug 2026).
5.5 Services
Product Portfolio
| Product | Description / specification | Target customer | Notes |
|---|---|---|---|
Potassium chloride standard/granular ("60er Kali", ~60% K2O) | Commodity MOP, granular for blending/direct application | Overseas distributors (Brazil, Asia), bulk blenders | Produced at Bethune and German sites; Bethune output fully KCl |
Kali 40-type products (~40% K2O with Na/Mg) | Lower-grade potash with sodium for grassland/beet | European farmers | Regional European product |
Fine/soluble KCl | Fertigation and NPK granulation feed | NPK producers | Also sold via Industry+ |
| Product | Description | Target crop/customer | Notes |
|---|---|---|---|
Korn-Kali | Potassium chloride with magnesium and sulfur (granular) | Arable crops, grassland in Europe | Flagship European K-Mg product |
Patentkali | Potassium sulfate + magnesium sulfate (chloride-low) | Chloride-sensitive crops: potatoes, fruit, vegetables, vines | Flagship specialty |
KALISOP | Sulfate of potash (~50% K2O, 45% SO3) | Chloride-sensitive high-value crops | SOP produced from kieserite/KCl conversion |
SOLUSOP | Fully water-soluble SOP | Fertigation, greenhouse | Specialty grade |
ESTA Kieserit (granular/fine) | Magnesium sulfate monohydrate, produced via ESTA electrostatic separation | Arable crops, oil palm, NPK producers | ESTA process is a K+S proprietary dry separation technology |
EPSO Top | Magnesium sulfate heptahydrate (Epsom salt), foliar/fertigation | Horticulture, fruit, foliar applications | Water-soluble specialty |
EPSO Microtop / EPSO Combitop | Epsom salt with boron/manganese, or zinc/manganese | Micronutrient correction | Premium micronutrient specialties |
Magnesia-Kainit | Low-grade K-Mg-Na product | Grassland, sugar beet | Regional product |
| Product family | Description | Customers |
|---|---|---|
Industrial KCl (high purity) | Feedstock for potassium hydroxide/carbonate, chlor-alkali | Chemical industry |
Pharmaceutical / food-grade potassium & sodium salts (APISAL range) | GMP-grade KCl/NaCl for infusion, dialysis, low-sodium foods | Pharma, medical, food |
Technical potassium sulfate | Industrial SOP | Chemicals, glass |
Magnesium sulfate/chloride (technical) | Kieserite/Epsom/magnesium chloride for industry | Chemicals, textiles, feed |
Oil-field brines/KCl for drilling | Clay stabilisation in drilling fluids | Oil & gas service companies |
| Product family | Description | Customers |
|---|---|---|
De-icing salt (rock salt, brine) | Road salt, tenders typically annual | Municipalities, highway authorities in Germany, Benelux, Scandinavia, France |
Salt for chemical use | Rock/evaporated salt for chlor-alkali/soda ash | Chemical industry |
Food-grade and table salt | Evaporated vacuum salt, iodised salts | Food processors, retail |
Water-softening salt (axal brand) | Tablets for domestic/industrial softeners | Consumers, industrial water treatment |
Feed salt / licks | Livestock salt | Agriculture |
| Service | Description | Status |
|---|---|---|
Waste management & recycling | Underground reuse/disposal of mineral waste in mined-out cavities (REKS JV with REMEX) | Operating; revenue n/d |
Logistics | Port terminal and bulk logistics services (e.g., Kali-Transport Gesellschaft, Hamburg) | Mostly captive |
Digital customer portal (myK+S) | Ordering/account platform for customers | Operating |
Financial Narrative
Important context: FY2021 includes the gain on the Americas divestment and impairment reversals; FY2022 was a price-shock record year; FY2025 includes a €1,575M net non-cash impairment (≈€2.06bn H1 impairment less €484M Q4 write-back) on the Potash and Magnesium Products CGU.
6.1 Income statement (€ M)
Sources: Revenue/EBITDA FY2023–2025 from K+S press releases and Facts & Figures; FY2021–2022 revenue/EBITDA consistent with K+S annual reports as compiled by MarketScreener; reported net results FY2021–FY2025 from boersengefluester (compiled from annual reports). Discrepancy: MarketScreener shows FY2024 net income -66.8 and FY2025 -1,600 (pre-write-back estimate); boersengefluester shows -66.5 and -1,075.5. The company's adjusted figure for FY2025 is -1,130.7. Gross profit, operating income (EBIT I), and pre-tax income for all years: not captured from primary statements in this research cycle (n/d) — K+S does not use gross profit as a KPI; consult the consolidated income statement in each annual report.
6.2 Margins
Revenue CAGR FY2021–FY2025: +3.2% p.a. (derived: 3,647.9 / 3,213, four periods); FY2022–FY2025: -13.7% p.a. — the post-2022 normalisation dominates.
6.3 Balance sheet (€ M unless stated)
Derivations: equity = book value per share × 179.1M shares; total assets = equity ÷ equity ratio. Net financial position from Q4/2025 Facts & Figures. Aggregator net-debt series (MarketScreener) uses a different definition and excludes mining provisions. K+S's broader "net debt" definition additionally includes long-term mining provisions (company IR page cites €1,061.7M of non-current mining provisions due beyond 10 years), which explains why EV (€3.8bn) materially exceeds market cap (€2.2bn) at end-2025. Cash & equivalents, short/long debt split, goodwill & intangibles and working capital: n/d in this cycle (consult Annual Report 2025 balance sheet). Post-balance-sheet: €320M convertible issued June 2026 (gross debt up; cash held pending Qemetica closing).
6.4 Cash flow (€ M)
Sources: OCF/capex FY2024–25 from Q4/2025 Facts & Figures; adjusted FCF from FY2023–FY2025 press releases. FY2021–FY2023 capex derived from aggregator CAPEX/EBITDA ratios (MarketScreener) — treat as approximate. Dividends paid derived as prior-year DPS × shares (≈191M for FY2021 dividend paid 2022; 179.1M thereafter) — approximate. FY2022 buyback: K+S executed a buyback in 2022 that reduced shares to 179.1M; value n/d in this cycle.
6.5 Ratios
Notes: ROE/ROA FY2025 derived on year-end equity/assets (distorted by impairment); FY2025 ROCE excludes impairment effects. Current ratio, interest coverage, debt/equity and cash conversion cycle: n/d (require full balance sheet/notes). K+S was in a net cash or near-zero net financial liability position from FY2022 to FY2025 on its narrow definition.
6.6 Commentary
Revenue trend: FY2021–FY2025 is a full potash cycle in miniature. FY2022 revenue (€5.68bn) was inflated by the post-invasion supply shock (Belarusian/Russian potash sanctions and logistics disruption) that pushed Brazil MOP above US$1,000/t. The 32% decline in FY2023 was almost entirely price-driven: Agriculture revenue fell from ~€4.5bn to €2.72bn while volumes rose. FY2024 and FY2025 were essentially flat at €3.65bn: in FY2025 a +5% Agriculture price (adj. €316 → €332/t) offset a 3% volume decline and a weaker USD; Industry+ prices for salt stayed high while weather reduced de-icing volumes by 11%.
Profitability inflection: EBITDA troughed at €558M in FY2024 (margin 15.3%) — the lowest since the Americas divestment — and recovered to €613M in FY2025 on higher prices and lower freight, partly offset by higher energy and personnel cost. 2026 is a clear upward inflection: H1/2026 EBITDA €455M (+47%), margin 22.3%, and guidance raised twice to €680–760M.
Impairment: The FY2025 net loss is non-cash: the July 2025 impairment (~€2bn) was driven mainly by a USD 0.10 per EUR increase in the long-term exchange-rate assumption, plus lower long-term potash price decks and a higher cost of capital; a €484M partial reversal in Q4 left a net €1,575M charge. Book value per share fell 21% to €27.3.
Cash flow: The binding constraint is capex. Capex rose from ~€344M (FY2021) to €546M (FY2025) and €600M guided for FY2026 as Werra 2060 (€600M total) and Ramp-up Bethune run in parallel. Operating cash flow of ~€575M has been almost fully consumed, compressing adjusted FCF to €62M (FY2024) and €29M (FY2025), with dividends falling mechanically under the 30–50%-of-FCF payout policy (€0.70 → €0.15 → €0.07).
Balance sheet: Despite minimal FCF, leverage is low: net financial liabilities of just €41M at end-2025 and a 63.5% equity ratio. This conservatism underpins the BBB- rating and gave room for the June 2026 €320M convertible to fund the Qemetica acquisition.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment
| Segment | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Agriculture revenue (EUR Mn) | 2,720 | 2,550.1 | 2,547.7 |
Industry+ revenue (EUR Mn) | 1,150 | 1,102.9 | 1,100.2 |
Group revenue (EUR Mn) | 3,873 | 3,653.1 | 3,647.9 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment Margins & Growth (%) and Revenue by Segment (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Agriculture YoY growth (%) | -40 | -6.2 | -0.1 |
Industry+ YoY growth (%) | — | -4.1 | -0.2 |
Agriculture share of group revenue (%) | 70.2 | 69.8 | 69.8 |
Industry+ share of group revenue (%) | 29.7 | 30.2 | 30.2 |
Operating Metrics (Mt) and Share Price
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Agriculture volumes incl. trade goods (Mt) | — | 7.90 | 7.57 |
Agriculture volumes excl. trade goods (Mt) | 7.2 | 7.56 | 7.31 |
Agriculture avg price adj. by trade goods (EUR per t) | — | 316.2 | 332.0 |
Industry+ volumes (Mt) | 6.62 | 6.58 | 6.26 |
of which de-icing salt (Mt) | — | 1.96 | 1.75 |
Revenue by Segment and Operating Metrics (Mt)
| Metric | Q1/2025 | Q1/2026 | Q2/2025 | Q2/2026 |
|---|---|---|---|---|
Agriculture revenue (EUR Mn) | 664.8 | ~678 | 617.8 | 700 |
Industry+ revenue (EUR Mn) | ~300 | 382.7 | 254 | 278 |
Agriculture volume excl. trade goods (Mt) | 1.97 | — | 1.74 | 1.90 |
Industry+ volume (Mt) | — | — | 1.31 | 1.47 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (EUR Mn) | 3,213 | 5,677 | 3,873 | 3,653.1 | 3,647.9 |
EBITDA (EUR Mn, K+S definition) | 969.1 | 2,423.2 | 712.4 | 557.7 | 612.8 |
Ordinary D&A (EUR Mn) | — | — | — | 559.8 | 458.3 |
Group earnings after tax, reported basis (EUR Mn) | 2,983 | 1,508 | 210.2 | -66.5 | -1,075.5 |
Adjusted Group earnings after tax (EUR Mn) | — | 1,494 | 162 | 3.6 | -1,130.7 |
Adjusted earnings excl. impairment effects (EUR Mn) | — | — | — | 3.6 | 125.5 |
Adjusted EPS (EUR) | — | — | — | 0.02 | -6.31 |
Adjusted EPS excl. impairment (EUR) | — | — | — | 0.02 | 0.70 |
Dividend per share (EUR) | 0.20 | 1.00 | 0.70 | 0.15 | 0.07 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
EBITDA margin (%) | 30.2 | 42.7 | 18.4 | 15.3 | 16.8 |
Adjusted net margin (%) | — | 26.3 | 4.2 | 0.1 | -31.0 |
Adjusted net margin excl. impairment (%) | — | — | — | 0.1 | 3.4 |
Margin Analysis (%) and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Equity ratio (%) | — | — | — | 66.5 | 63.5 |
Book value per share (EUR) | — | — | — | 34.7 | 27.3 |
Total equity (EUR Mn, derived) | — | — | — | 6,215 | 4,889 |
Total assets (EUR Mn, derived) | — | — | — | 9,346 | 7,700 |
Net financial position, K+S definition (EUR Mn; positive = net cash) | — | — | — | 31.1 | -41.1 |
Net debt per aggregator (EUR Mn; negative = net cash) | 1,124 | -255 | -123 | -53.8 | -19.3 |
Senior bonds outstanding (EUR Mn) | — | — | — | 500 | 500 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Net cash flow from operating activities (EUR Mn) | — | — | — | 583.0 | 572.7 |
Capital expenditure, cash (EUR Mn) | 344 | 356 | 470 | 530.8 | 545.8 |
Adjusted free cash flow (EUR Mn) | — | 932 | 311.2 | 62.4 | 29.1 |
Dividend paid in year (EUR Mn) | — | 38 | 179 | 125 | 27 |
Share buybacks (EUR Mn) | 0 | — | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROCE, K+S definition (%) | — | — | — | 0.0 | 1.9 |
ROE on adjusted earnings (%, derived) | — | — | — | 0.1 | -20.4 |
ROA on adjusted earnings (%, derived) | — | — | — | 0.04 | -13.2 |
Capex / EBITDA (%) | 35.5 | 14.7 | 66.0 | 95.2 | 89.1 |
Net financial liabilities / EBITDA (x) | — | 0 | 0 | 0 | 0.07 |
Asset turnover (x, derived) | — | — | — | 0.39 | 0.47 |
Revenue by Region
| Region | FY2024 | FY2025 |
|---|---|---|
Europe (EUR Mn) | 1,182.5 | 1,213.6 |
Overseas (EUR Mn, derived) | 1,367.6 | 1,334.1 |
Overseas (USD Mn, as reported) | 1,479.9 | 1,508.4 |
Operating Metrics (Mt) and Share Price (FY2024–FY2025)
| Metric | FY2024 | FY2025 |
|---|---|---|
Europe volume (Mt) | 3.45 | 3.45 |
Overseas volume (Mt) | 4.45 | 4.12 |
Europe average price (EUR per t) | 342.5 | 351.4 |
Overseas average price (USD per t) | 332.5 | 366.4 |
Revenue by Region (Quarterly)
| Region | Q2/2025 | Q2/2026 | Growth (%) |
|---|---|---|---|
Europe (EUR Mn) | 290 | 281 | -3.1 |
Overseas (EUR Mn) | 328 | 419 | 27.7 |
Valuation Snapshot
| Metric | Value | Source/date |
|---|---|---|
Share price | ~€15.6–16.4 (late Sep 2026) | Lang & Schwarz via boerse-express, 18–28 Sep 2026 |
52-week range | €10.73 – €18.16 (high on 13 Mar 2026) | boerse-express |
1-year performance | ~+32% to +47% depending on date (late Sep 2026) | boerse-express / wallstreet-online |
YTD 2026 | ~+6% at end-June 2026 per H1 report; ~+25–30% by late Sep (derived from ~€12.3 year-end) | K+S H1/2026; derived |
Market cap | ~€2.9bn (Sep 2026); €2.2bn (31 Dec 2025); €1.9bn (31 Dec 2024) | Aggregators; K+S |
Peer performance H1/2026 | Mosaic -12%, ICL -16%, Nutrien +2% | K+S H1/2026 report |
Market Valuation and Per-Share Data
| Metric | FY2024 | FY2025 |
|---|---|---|
Market cap at 31 Dec (EUR Bn) | 1.9 | 2.2 |
Enterprise value at 31 Dec (EUR Bn) | 3.3 | 3.8 |
Book value per share (EUR) | 34.7 | 27.3 |
Valuation Multiples
| Multiple | K+S (derived) | Basis |
|---|---|---|
EV/EBITDA 2026e | ~6.2x | EV ≈ €4.5bn (market cap €2.9bn + ~€1.6bn non-equity claims per end-2025 EV bridge) / €720M guidance midpoint |
EV/Sales 2026e | ~1.1x | EV / ~€4.0bn revenue (H1 run-rate) |
P/B | ~0.6x | €2.9bn / €4.89bn equity (end-2025) |
P/E 2026e | ~13x | ~€16 / consensus EPS ~€1.25 (aggregator, 14 analysts, Sep 2026) |
Dividend yield (trailing) | ~0.4–0.5% | €0.07 DPS |
Per-Share Data and Dividends & Capital Returns
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividend per share (EUR) | 0.20 | 1.00 | 0.70 | 0.15 | 0.07 |
Total payout (EUR Mn) | — | 179 | 125 | 27 | 13 |
Payout as % of adjusted FCF | — | 19 | 40 | 43 | 43 |
Credit Ratings
| Agency | Rating | Outlook | Last update |
|---|---|---|---|
S&P Global Ratings | BBB- | Stable | 18 Jun 2026 (unchanged since 5 Jun 2023) |
Moody's | Not rated (n/d) | — | — |
Fitch | Not rated (n/d) | — | — |
Capital Instruments
| Instrument | Amount (EUR Mn) | Coupon | Maturity |
|---|---|---|---|
Senior unsecured bond (issued 19 Jun 2024) | 500 | n/d in this cycle | 19 Jun 2029 |
Convertible bonds (ISIN DE000A460GW7; issued 16 Jun 2026) | 320 | 0.625% | 16 Jun 2031 |
Analyst Conclusions
Management guidance (12 Aug 2026): FY2026 EBITDA €680–760M (vs. €613M in 2025); adjusted FCF positive in the mid- to high-double-digit € millions; capex ~€600M; midpoint assumes H2 Agriculture prices hold at mid-year levels, current freight costs, and gas at €45/MWh. The Q2 update explicitly flags that production limits at Unterbreizbach (low water) would hurt EBITDA.
Consensus expectations: Revenue ~€3.7–4.0bn in 2026 (aggregator range; H1 run-rate suggests the upper half), EBITDA ~€720M, EPS ~€1.25 (2026e) and ~€1.33 (2027e); 2027 EBITDA expected roughly flat to slightly lower on aggregator data (MarketScreener ~€634M, pre-upgrade) — dispersion is wide.
Bull case
-
Potash tightness persists: capacity was fully utilised in 2025; Brazil imports hit records in H1/2026; K+S's Q2 overseas Agriculture revenue rose 28%. Each sustained US$25/t on KCl drives disproportionate EBITDA given fixed-cost operating leverage (H1 margin up 5.4 points).
-
Capex cliff after 2028: once Werra 2060 and Bethune ramp-up complete, capex could fall from ~€600M toward maintenance levels, transforming FCF from ~€30–90M to several hundred million, with a 30–50% payout policy driving a dividend recovery.
-
Valuation support: ~0.6x book, ~6x EV/EBITDA on a BBB- balance sheet; Qemetica adds stable salt earnings bought at a reasonable multiple, financed at 0.625%.
Bear case
-
License-to-operate risk: the post-2027 Werra discharge permit is unresolved and politically contested (Lower Saxony, NGOs); any restriction would cut German output — the 2016 production stoppages are the precedent.
-
Structural cost and FX disadvantage: high-cost German assets with a EUR cost base against USD prices produced a €1.6bn net impairment in 2025 and ROCE of only 1.9%; a renewed USD slide or gas spike erodes earnings quickly.
-
Execution and supply: Werra 2060 has already slipped to 2028 (with market reports questioning even that); Bethune remains below targeted output; BHP Jansen and Russian expansions threaten price recovery late in the decade.
Catalysts and monitorables (next 12 months)
-
Q3/2026 results (10 Nov 2026): EBITDA delivery vs. €680–760M, Werra 2060 timeline confirmation.
-
Werra water-law permit process for post-2027 discharges; outcome of political negotiations among Hesse, Thuringia and Lower Saxony.
-
River water levels and any Unterbreizbach production limitations.
-
Brazil KCl price trajectory through the Q4 2026 and Q1 2027 seasons; USD/EUR.
-
Qemetica antitrust clearance and closing (expected Q1 2027).
-
FY2026 results and FY2027 guidance (March 2027); dividend proposal under the 30–50% FCF policy.
-
European gas prices and Middle East developments.
-
Board renewals (Labor Director mandate ran to 2026).
Concluding analyst verdict. K+S enters late 2026 in a materially better operating position than at any time since 2023. Two consecutive guidance upgrades, H1 EBITDA up 47%, improving potash prices, a weather windfall in salt, and a well-financed bolt-on acquisition show a management team under CEO Christian Meyer executing credibly in its first full year. The balance sheet remains a genuine strength: near-zero net financial debt, a BBB- rating and ready access to cheap convertible funding give K+S the capacity to self-fund its two major projects, as management insists it will.
The equity story, however, remains one of transformation risk priced against cyclical upside. The company's returns are structurally low — ROCE of 1.9% in 2025 even before impairment — because the German asset base is expensive to run and capital-hungry to modernise, while revenue is set in dollars. Free cash flow is likely to stay thin through 2028 as ~€600M per year flows into Werra 2060 and Bethune, keeping the dividend token. Most importantly, the single largest value driver is not the potash price but regulation: the post-2027 wastewater discharge permit for the Werra, now openly contested by a neighbouring state government, and the hydrology that constrains production in dry summers. Until that permit path is secured and Werra 2060 is demonstrably on schedule, the market will continue to apply a discount to book value.
On balance, we view K+S as a cyclically supported but structurally challenged holding: fairly valued at ~6x EV/EBITDA on 2026 guidance, with upside skew if potash prices hold into 2027 and the permit issue is resolved constructively, and meaningful downside if regulatory or water constraints bite. The stance corresponds to a Neutral / Hold, with the Q3 report (10 Nov 2026) and permit developments as the decisive near-term signposts. This verdict is analytical commentary based on public information and is not investment advice.
Data gaps flagged for follow-up (from Annual Report 2025 primary statements): gross profit, EBIT and pre-tax income series; cash and debt split; goodwill/intangibles; working capital; interest coverage; R&D spend; executive compensation by member; auditor; top-10 shareholders; ESG ratings; group revenue by geography; 3- and 5-year total shareholder return.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | On board since | Current mandate to | Prior roles / notes |
|---|---|---|---|---|
Dr. Christian H. Meyer | Chairman of the Board of Executive Directors (CEO) | Mar 2023 (CFO); CEO from 1 Jun 2025 | Mar 2031 | Joined as CFO 2023; prior career: n/d in this cycle (see K+S board CVs) |
Dr. Carin-Martina Tröltzsch | Deputy Chair; Chief Operating Officer | n/d (pre-2024) | Feb 2029 | Responsible for operations/production |
Dr. Jens Christian Keuthen | Chief Financial Officer | 1 Feb 2025; CFO from 1 Jun 2025 | 2,028 | Previously Head of Legal, Tax, Regulatory Affairs and New Business Areas at K+S |
Christina Daske | Member; Labor Director (HR) | — | 2026 (per Aug 2025 release; renewal status n/d) | Labor director under co-determination law |
Governance Overview
| Feature | Detail |
|---|---|
Chair | Dr. Harald Schwager (former BASF Executive Board member; succeeded Dr. Andreas Kreimeyer, who chaired during the 2024 CEO succession) |
Size / composition | 12 members under the German Co-Determination Act: 6 shareholder representatives, 6 employee representatives (standard for K+S; verify current roster) |
Committees | Audit Committee; Personnel Committee; Nomination Committee; Mediation Committee (§27 MitbestG); Sustainability/Strategy committee (verify) |
Independence | German Corporate Governance Code independence assessments published in Declaration on Corporate Governance; specific count n/d |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
23 Oct 2024 | Announcement: Lohr not to extend; Meyer named CEO-designate; Tröltzsch named Deputy Chair; Keuthen appointed to board | Planned succession |
1 Feb 2025 | Keuthen joins Executive Board | Internal appointment |
1 Jun 2025 | Meyer CEO; Keuthen CFO | Effective succession |
29 Aug 2025 | Meyer mandate renewed to Mar 2031; Tröltzsch to Feb 2029 | Continuity signal from Supervisory Board Chair Schwager |
Competitive Landscape
Key Competitors
| Competitor | Segment overlap | Positioning vs. K+S |
|---|---|---|
Nutrien (Canada) | Potash (KCl) | World's largest potash producer; low-cost Saskatchewan conventional mines; integrated retail |
The Mosaic Company (US) | Potash, phosphate | Major Saskatchewan potash producer; Brazil distribution (Mosaic Fertilizantes) |
Belaruskali (Belarus) | Potash | Large low-cost producer under Western sanctions; rerouted via Russia |
Uralkali (Russia) | Potash | Large low-cost producer; continues to sell in EU (per K+S) |
EuroChem (Russia/Switzerland) | Potash, complex fertilizers | New potash mines (Usolskiy, VolgaKaliy) |
ICL Group (Israel) | Potash (Dead Sea, Spain), specialties, polysulphate | Direct specialties competitor in Europe; Spanish potash |
Arab Potash Company (Jordan) | Potash | Low-cost Dead Sea producer |
SQM (Chile) | SOP/specialty potassium nitrate | Specialty plant nutrition competitor |
BHP (Jansen, Canada) | Potash (future) | Greenfield capacity from late 2020s adds supply |
Tessenderlo (Belgium) | SOP | European SOP competitor |
Südwestdeutsche Salzwerke (Germany) | Salt | Main German salt competitor |
Salins Group (France) | Salt | French/European salt |
Nobian (Netherlands) | Salt (chemical/industrial) | European salt |
Compass Minerals (US/UK) | Salt, SOP | UK/North American salt (UK Winsford mine) |
Cargill Salt | Salt | Global salt |
Peer Comparison FY2024
| Metric | K+S | Nutrien | Mosaic | ICL |
|---|---|---|---|---|
Revenue FY2024 (USD Bn, approx) | 3.95 | 26.0 | 11.1 | 6.8 |
Revenue growth FY2024 (%) | -5.7 | -10 | -19 | -9 |
EBITDA margin FY2024 (%) | 15.3 | ~21 | ~20 | ~21 |
Business mix | Potash + salt | Potash, N, P + retail | P + potash | Potash, bromine, phosphate specialties |
Recent Developments
--



